Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer.

× No keyword cloud information.

17 in total

Review 1. Macrocyclic inhibitors of hsp90.

Authors: Victoria A Johnson; Erinprit K Singh; Lidia A Nazarova; Leslie D Alexander; Shelli R McAlpine
Journal: Curr Top Med Chem Date: 2010 Impact factor: 3.295

2. A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues.

Authors: Lata T Gooljarsingh; Christine Fernandes; Kang Yan; Hong Zhang; Michael Grooms; Kyung Johanson; Robert H Sinnamon; Robert B Kirkpatrick; John Kerrigan; Tia Lewis; Marc Arnone; Alastair J King; Zhihong Lai; Robert A Copeland; Peter J Tummino
Journal: Proc Natl Acad Sci U S A Date: 2006-05-09 Impact factor: 11.205

3. Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET.

Authors: Peter M Smith-Jones; David Solit; Farzana Afroze; Neal Rosen; Steven M Larson
Journal: J Nucl Med Date: 2006-05 Impact factor: 10.057

4. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.

Authors: Kunihiro Uryu; Christiane Richter-Landsberg; William Welch; Eveline Sun; Olaf Goldbaum; Erin H Norris; Chi-Tuan Pham; Ikuru Yazawa; Kristen Hilburger; Matthew Micsenyi; Benoit I Giasson; Nancy M Bonini; Virginia M-Y Lee; John Q Trojanowski
Journal: Am J Pathol Date: 2006-03 Impact factor: 4.307

5. Thermodynamic Analysis of the Geldanamycin-Hsp90 Interaction in a Whole Cell Lysate Using a Mass Spectrometry-Based Proteomics Approach.

Authors: Yingrong Xu; M Ariel Geer Wallace; Michael C Fitzgerald
Journal: J Am Soc Mass Spectrom Date: 2016-08-16 Impact factor: 3.109

Review 6. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.

Authors: Masahiro Waza; Hiroaki Adachi; Masahisa Katsuno; Makoto Minamiyama; Fumiaki Tanaka; Manabu Doyu; Gen Sobue
Journal: J Mol Med (Berl) Date: 2006-06-02 Impact factor: 4.599

7. Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer.

Authors: Magdalena Zajac; Gonzalo Gomez; Javier Benitez; Beatriz Martínez-Delgado
Journal: BMC Med Genomics Date: 2010-10-04 Impact factor: 3.063

Review 8. [Role of androgen receptors in hormone-refractory prostate cancer: molecular basics and experimental therapy approaches].

Authors: L Rinnab; A Hessenauer; S V Schütz; E Schmid; R Küfer; F Finter; R E Hautmann; K D Spindler; M V Cronauer
Journal: Urologe A Date: 2008-03 Impact factor: 0.639

9. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.

Authors: Junkui Ai; Yujuan Wang; Javid A Dar; June Liu; Lingqi Liu; Joel B Nelson; Zhou Wang
Journal: Mol Endocrinol Date: 2009-10-23

10. Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy.

Authors: Yoshihiro Nihei; Daisuke Ito; Yohei Okada; Wado Akamatsu; Takuya Yagi; Takahito Yoshizaki; Hideyuki Okano; Norihiro Suzuki
Journal: J Biol Chem Date: 2013-01-30 Impact factor: 5.157